SCHEMBL18177566

SCHEMBL18177566

CC(=O)N[C@H]1[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O[C@H]3[C@H](OS(=O)(=O)O)[C@@H](NS(=O)(=O)O)[C@@H](O[C@H]4[C@H](O)[C@@H](OS(=O)(=O)O)[C@H](O[C@H]5[C@H](O)[C@@H](NS(=O)(=O)O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O[C@H]7[C@H](O)[C@@H](NC(C)=O)C(O)O[C@@H]7COS(=O)(=O)O)O[C@H]6C(=O)O)O[C@@H]5COS(=O)(=O)O)O[C@H]4C(=O)O)O[C@@H]3COS(=O)(=O)O)O[C@@H]2C(=O)O)O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]2O[C@@H](C(=O)O)[C@@H](C)[C@H](O)[C@H]2O)[C@@H]1O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 3/20 0.72
BDNF P23560 3/20 0.51
PTN P21246 2/20 0.51
MDK P21741 2/20 0.51
BMP2 P12643 2/20 0.48
VEGFA P15692 2/20 0.48
CXCL12 P48061 2/20 0.48
SHH Q15465 2/20 0.48
IFNG P01579 1/20 0.48
PF4 P02776 1/20 0.48
CCL2 P13500 1/20 0.48
SELP P16109 1/20 0.48
BMP6 P22004 1/20 0.48
CCL11 P51671 1/20 0.48
WNT3A P56704 1/20 0.48
SELPLG Q14242 1/20 0.48
SERPINC1 P01008 2/20 0.47
F2 P00734 1/20 0.47
HPSE Q9Y251 8/20 0.45
FGF2 P09038 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17771214 1.00 F10 (0.72) F10BDNFPTNMDKBMP2
SCHEMBL15452257 1.00 F10 (0.72) F10BDNFPTNMDKBMP2
SCHEMBL15452278 1.00 F10 (0.72) F10BDNFPTNMDKBMP2
SCHEMBL17771212 0.99 F10 (0.72) F10BDNFPTNMDKBMP2
SCHEMBL18177564 0.99 F10 (0.72) F10BDNFPTNMDKBMP2
SCHEMBL15452228 0.99 F10 (0.72) F10BDNFPTNMDKBMP2
SCHEMBL15452260 0.99 F10 (0.72) F10BDNFPTNMDKBMP2
SCHEMBL17771211 0.98 F10 (0.70) F10BDNFPTNMDKBMP2
SCHEMBL15452234 0.98 F10 (0.70) F10BDNFPTNMDKBMP2
SCHEMBL17771208 0.98 F10 (0.70) F10BDNFPTNMDKBMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160310521-A1 POLYSACCHARIDES COMPRISING TWO ANTITHROMBIN III-BINDING SITES, PREPARATION THEREOF AND USE THEREOF AS ANTITHROMBOTIC MEDICAMENTS SANOFI (FR) 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160310521-A1 POLYSACCHARIDES COMPRISING TWO ANTITHROMBIN III-BINDING SITES, PREPARATION THEREOF AND USE THEREOF AS ANTITHROMBOTIC MEDICAMENTS SERPINC1, F13B, F12 F10 14/4885BDNF 2533/4885PTN 361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.